Latest Insights on ON

abbvie stock Profit From AbbVie’s Struggles Today Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
The coronavirus outbreak is setting up a huge rally for the rest of the year — and you won’t want to miss out. Your Coronavirus Crisis Plan: Watch for This Rally The coronavirus outbreak is setting up a huge rally for the rest of the year — and you won’t want to miss out.
What the Latest Earnings Reports Really Tell Us About Amazon, Tesla and the S&P 500 [15-minute video] How the latest outbreak will impact certain stocks.
coronavirus Coronavirus Alert — Grab Double-Digit Gains When Stocks Rebound The coronavirus is spreading faster than the SARS outbreak in 2003. Markets are falling on fear of a global slowdown. But quick action from world leaders is helping contain the virus. Matt Badiali shares a contrarian strategy for buying great stocks at discounted prices.
Please take a moment to answer our three-question Super Bowl survey now. Take Our Super Bowl Survey Now!
by February 2, 2020 Winning Investor Daily
Sunday night is the Super Bowl! Let us know what you think by taking this three-question now.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"

- Keith S.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This